Diabetes management in older adults with chronic kidney disease
KK Clemens, N O'Regan, JJ Rhee - Current diabetes reports, 2019 - Springer
Abstract Purpose of Review Older adults often live with chronic disease including diabetes
and its complications. In this review, we examine the complexity and heterogeneity of older …
and its complications. In this review, we examine the complexity and heterogeneity of older …
Association between incretin-based drugs and the risk of acute pancreatitis
Importance The association between incretin-based drugs, such as dipeptidyl peptidase 4
(DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) agonists, and acute pancreatitis is …
(DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) agonists, and acute pancreatitis is …
The risk of acute pancreatitis after initiation of dipeptidyl peptidase 4 inhibitors: testing a hypothesis of subgroup differences in older US adults
OBJECTIVE To examine whether dipeptidyl peptidase 4 inhibitors (DPP-4I) increase acute
pancreatitis risk in older patients and whether the association varies by age, sex, and history …
pancreatitis risk in older patients and whether the association varies by age, sex, and history …
Lithium toxicity following co-prescription of lithium and ACEI/ARBs: A population-based cohort study
F Ahmadi - 2022 - search.proquest.com
Guidelines caution against co-prescribing angiotensin-converting enzyme inhibitors (ACEIs)
or angiotensin receptor blockers (ARBs) together with lithium, as this may increase lithium …
or angiotensin receptor blockers (ARBs) together with lithium, as this may increase lithium …
[PDF][PDF] 急性胰腺炎患者病情严重程度与胸腔积液的相关性研究
杨涓， 郑盛， 张帆， 王玉波， 唐映梅 - 现代生物医学进展, 2017 - biomed.cnjournals.com
摘要目的: 探讨急性胰腺炎(AP) 患者病情严重程度与胸腔积液的相关性. 方法:
回顾性分析云南省第三人民医院2008 年1 月至2014 年12 月收治的492 例AP 患者的临床资料 …
回顾性分析云南省第三人民医院2008 年1 月至2014 年12 月收治的492 例AP 患者的临床资料 …
[PDF][PDF] Sitagliptin and Acute Pancreatitis: A Systematic Review and Meta-analysis
HO Mirghani, SAS Shaman, IMH Aljwah - researchgate.net
ABSTRACT Background and Objectives: Sitagliptin is a dipepidyl peptidase inhibitor (DPP-
4i) with gentle antidiabetic effects with a lower risk of hypoglycemia. The association with …
4i) with gentle antidiabetic effects with a lower risk of hypoglycemia. The association with …
Sodium-Glucose Cotransporter-2 Inhibitor Use and the Risk of Acute Kidney Injury in Older Adults in Routine Clinical Practice: A Population-Based Cohort Study
C Iskander - 2019 - search.proquest.com
Regulatory agencies warn about acute kidney injury (AKI) risk following sodium-glucose
cotransporter-2 (SGLT2) inhibitor use. This population-based retrospective cohort study in …
cotransporter-2 (SGLT2) inhibitor use. This population-based retrospective cohort study in …
Tip 2 diabetes mellitus tanılı hastalarda dipeptidil peptidaz-4 inhibitörlerinin açlık-tokluk kan şekeri, HbA1C, kreatin, ALT, amilaz ve lipaz değerleri üzerine etkileri
G İnan Demiroğlu - acikbilim.yok.gov.tr
Giriş ve amaç: Diabetes mellitus sistemik etkileri olan kronik bir metabolizmahastalığıdır. Tip
2 DM tedavisinde kullanılan DPP-4 inhibitörleri HbA1c'yi ortaderecede düşüren oral …
2 DM tedavisinde kullanılan DPP-4 inhibitörleri HbA1c'yi ortaderecede düşüren oral …
Effectiveness of sitagliptin vs sulphonylureas for managing type 2 diabetes mellitus in clinical practice
M Sharma - 2018 - discovery.ucl.ac.uk
One challenging prescribing decision in type 2 diabetes mellitus (T2DM) is when clinicians
must choose between sitagliptin and sulphonylureas as add-on to metformin based on …
must choose between sitagliptin and sulphonylureas as add-on to metformin based on …
[CITATION][C] Sitagliptin and Acute Pancreatitis: A Systematic Review and Meta-analysis
H Osman Mirghani, ASSS Shaman… - 2021 - JPRI
